At Seton Pharmaceuticals, our dedicated team of professionals has years of experience working in the pharmaceutical industry. We have proven success with the handling, shipping, receiving and returns of our pharmaceutical products. Our expertise in the marketplace and strong attention to detail has helped us become a leader among generic pharmaceutical companies.
The Seton Pharmaceuticals team consists of three national sales representatives. These representatives work directly with customers to develop the perfect promotional plan for our products. Our team also deals with specific product distribution to a wide variety of retail chains, wholesalers, generic distributors and mail order accounts.
Our team of customer service professionals will do everything possible to ensure the quality of your product order. At Seton Pharmaceuticals, our customer service team processes all orders and tracks deliveries. If you have any questions about your order, our team will be glad to answer them immediately. Our pharmaceutical company will also help with all of your promotional rebates and administrative fees.
The successful supply chain mastery that was developed by our team at Seton Pharmaceuticals has helped to increase our knowledge and understanding of the pharmaceutical industry. To learn more about our pharmaceutical team, contact Seton Pharmaceuticals today.
Matt has been in the pharmaceutical industry for over twenty years. Throughout his career Matt has orchestrated licensed agreements with Amneal, UCB, Hill Dermaceuticals and Symbiotec among others. Matt has also opened and expanded successful relationships with some of the largest and most prestigious US customers such as Walgreens, McKesson, and Econdisc. He graduated from Seton Hall University (BS) in 1986.
John P. O’Malley III
Chief Financial Officers
John joined the Company in September 2014. From 1998 to 2013 he was Executive Vice President – Finance and Chief Financial Officer of Westcon Group. Westcon Group is a global distributor of information technology communication equipment with sales in excess of $5 billion annually. From 1992 to 1997, Mr. O’Malley was Executive Vice President – Finance and Chief Financial Officer of Medical Resources, Inc. and its predecessor, NMR of America, Inc. These companies engaged in the operation of medical diagnostic imaging cetners throughout the US. From August 1984 to May 1992, Mr. O’Malley was employed by the public accounting firm of Ernst & Young LLP. Mr. O’Malley is a certified public accountant with a BS in accounting from the University of Delaware.
Executive Vice President Business Development
Chris started with Granard Pharmaceuticals in 1999 and currently drives all business development and strategic alliance initiatives on a global scale for Seton, Royal and Granard. Chris works within all aspects of product acquisition, licensing and development.
Vice President of National Accounts
David brings twenty years of pharmaceutical experience in generic and brand sales, wholesale supply chain and sourcing, institutional and retail national account management and business development. David’s previous company experience includes Abbot Labs, AstraZeneca, AmericourceBergen, Teva and Breckenridge.